AstraZeneca
Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration
The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to the statement.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
US to move COVID-19 vaccines, treatments to private markets in 2023
AION, aMoon up for top scientific innovation award
COVID-19 booster shots are crucial, according to a Yale study
New study by Yale, UNC, shows that peak antibody levels achieved by getting vaccinated with an mRNA vaccine exceed those gained from natural infection.
COVID-19: Blood cancer patients gain antibodies from vaccine booster - study
Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.
Eight Israeli start-ups to form international collaborations
Following BetterPlayBio’s program, C2i Genomic, Nucle.ai, Medial Earlysign, iBex, Octopus, Imagene, Itamar Medical and iCardio are ready to hit the global market.
COVID-19: Israel approves AstraZeneca's Evusheld vaccine for immunocompromised
Evusheld has proven to be 83% effective in preventing serious illness and death from COVID-19.
AstraZeneca: Trial shows booster generates more protection from Omicron
AstraZeneca has developed the vaccine with researchers from Oxford University.
2021 was the year of the coronavirus vaccine
“I think we are in a revolution that no one believed would happen.”
AstraZeneca vaccine booster shot effective against Omicron - Oxford lab study
An Oxford University lab study yet to be peer-reviewed found that three AstraZeneca vaccines provide protection against the COVID Omicron variant.
GOP Rep. Marjorie Taylor Green owns stock in 3 COVID-19 vaccine makers
The congresswoman owns stock in Pfizer, AstraZeneca and Johnson&Johnson despite claiming to be unvaccinated and being among the most vocal opponents of vaccine mandates.
Next pandemic could be more lethal than COVID - AstraZeneca vaccine maker
The novel coronavirus has killed 5.26 million people across the world, wiped out trillions of dollars in economic output and turned life upside down for billions of people.
AstraZeneca's antibody cocktail helps prevent COVID-19 for at least 6 months
The data give hope of additional protection for people who do not respond well to vaccines, such as cancer patients.